ImmunityBio, Inc.
← Back to IBRX Overview

ImmunityBio, Inc. (IBRX)

Solvency & Capital Structure

Total Debt

$1.12B

Net Debt

$743.7M

ImmunityBio, Inc. currently has $1.12B in total debt. Net debt is $743.7M after cash offsets.

Financial Fundamentals

IBRXQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-311.120.380.740.65173.9%
2025-12-310.880.240.640.50175.0%
2025-09-300.540.260.280.52104.5%
2025-06-300.540.150.380.40133.1%
2025-03-310.530.060.460.30173.3%
2024-12-310.500.150.350.38131.7%
2024-09-300.740.130.610.36203.8%
2024-06-300.740.220.520.44165.6%
2024-03-310.730.170.560.40182.5%
2023-12-310.730.270.460.50144.1%
2023-09-300.720.190.530.43165.9%
2023-06-300.820.050.770.29281.3%
2023-03-310.770.090.670.34223.1%
2022-12-310.720.110.620.36199.7%
2022-09-300.760.110.650.35215.8%
2022-06-300.720.080.630.32225.1%
2022-03-310.690.190.490.39175.8%
2021-12-310.650.320.330.47137.7%
2021-09-300.350.080.260.21160.9%
2021-06-300.330.100.230.25134.7%
2021-03-310.320.080.240.21152.6%
2020-12-310.280.100.180.22124.5%
2020-09-300.260.060.200.12222.5%
2020-06-300.010.11-0.10Net Cash0.206.4%
2020-03-310.010.04-0.03Net Cash0.1310.8%
2019-12-310.010.05-0.04Net Cash0.1410.4%
2019-09-300.020.07-0.05Net Cash0.1610.0%
2019-06-300.010.08-0.07Net Cash0.188.5%
2019-03-310.020.10-0.08Net Cash0.217.6%
2018-12-310.010.07-0.07Net Cash0.183.8%
2018-09-300.010.08-0.08Net Cash0.203.6%
2018-06-300.010.10-0.10Net Cash0.213.2%
2018-03-310.010.12-0.11Net Cash0.233.1%
2017-12-310.010.13-0.12Net Cash0.252.9%
2017-09-300.010.15-0.14Net Cash0.282.7%
2017-06-300.020.18-0.15Net Cash0.307.4%
2017-03-310.010.19-0.18Net Cash0.302.6%
2016-12-310.010.20-0.19Net Cash0.322.6%
2016-09-300.010.21-0.20Net Cash0.332.3%
2016-06-300.000.21-0.21Net Cash0.340.7%
2016-03-310.000.22-0.22Net Cash0.360.7%
2015-12-310.000.29-0.29Net Cash0.370.7%
2015-09-300.000.36-0.36Net Cash0.370.0%
2015-06-300.000.12-0.12Net Cash0.130.0%
2015-03-310.000.05-0.05Net Cash0.060.0%
2014-12-310.000.06-0.06Net Cash0.060.4%